Expression of vascular endothelial growth factor in oral squamous cell carcinoma

被引:10
作者
Kim, Seok-Kon [2 ]
Park, Seung-Goo [1 ]
Kim, Kyung-Wook [1 ]
机构
[1] Dankook Univ, Coll Dent, Dept Oral & Maxillofacial Surg, 119 Dandae Ro, Cheonan 330714, South Korea
[2] Dankook Univ, Coll Med, Dept Anesthesiol & Pain Med, Cheonan 330714, South Korea
关键词
Squamous cell carcinoma; Vascular endothelial growth factor; Real-time polymerase chain reaction; Immunohistochemistry;
D O I
10.5125/jkaoms.2015.41.1.11
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objectives: The goal of this study was to determine the correlation of clinicopathological factors and the up-regulation of vascular endothelial growth factor (VEGF) expression in oral squamous cell carcinoma. Materials and Methods: Immunohistochemical staining of VEGF and quantitative real-time polymerase chain reaction (RT-PCR) of VEGF mRNA were performed in 20 specimens from 20 patients with oral squamous cell carcinoma and another 20 specimens from 20 patients with carcinoma in situ as a controlled group. Results: The results were as follows: 1) In immunohistochemical study of poorly differentiated and invasive oral squamous cell carcinoma, high-level staining of VEGF was observed. Significant correlation was observed between immunohistochemical VEGF expression and histologic differentiation, tumor size of specimens (Pearson correlation analysis, significance r>0.6, P<0.05). 2) In VEGF quantitative RT-PCR analysis, progressive cancer showed more VEGF expression than carcinoma in situ. Paired-samples analysis determined the difference of VEGF mRNA expression level between cancer tissue and carcinoma in situ tissue, between T1 and T2-4 (Student's t-test, P<0.05). Conclusion: These findings suggest that up-regulation of VEGF may play a role in the angiogenesis and progression of oral squamous cell carcinoma.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 40 条
[1]   EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) AND ITS RECEPTORS IN BREAST-CANCER [J].
BROWN, LF ;
BERSE, B ;
JACKMAN, RW ;
TOGNAZZI, K ;
GUIDI, AJ ;
DVORAK, HF ;
SENGER, DR ;
CONNOLLY, JL ;
SCHNITT, SJ .
HUMAN PATHOLOGY, 1995, 26 (01) :86-91
[2]  
BROWN LF, 1993, CANCER RES, V53, P4727
[3]  
Byun June‑Ho, 2005, Maxillofacial Plastic Reconstructive Surgery, V27, P528
[4]  
권수경, 2005, Endocrinology and Metabolism, V20, P134
[5]   VASCULAR-PERMEABILITY FACTOR - A UNIQUE REGULATOR OF BLOOD-VESSEL FUNCTION [J].
CONNOLLY, DT .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1991, 47 (03) :219-223
[6]  
DVORAK HF, 1995, AM J PATHOL, V146, P1029
[7]   PRIMARY STRUCTURE OF BOVINE PITUITARY BASIC FIBROBLAST GROWTH-FACTOR (FGF) AND COMPARISON WITH THE AMINO-TERMINAL SEQUENCE OF BOVINE BRAIN ACIDIC FGF [J].
ESCH, F ;
BAIRD, A ;
LING, N ;
UENO, N ;
HILL, F ;
DENOROY, L ;
KLEPPER, R ;
GOSPODAROWICZ, D ;
BOHLEN, P ;
GUILLEMIN, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (19) :6507-6511
[8]   PITUITARY FOLLICULAR CELLS SECRETE A NOVEL HEPARIN-BINDING GROWTH-FACTOR SPECIFIC FOR VASCULAR ENDOTHELIAL-CELLS [J].
FERRARA, N ;
HENZEL, WJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) :851-858
[9]   Vascular endothelial growth factor as a target for anticancer therapy [J].
Ferrara, N .
ONCOLOGIST, 2004, 9 :2-10
[10]   The biology of vascular endothelial growth factor [J].
Ferrara, N ;
DavisSmyth, T .
ENDOCRINE REVIEWS, 1997, 18 (01) :4-25